Articles

Food with high antioxidant concentrations seems to have a protective effect, improving oxidative stress-mediated detrimental effects on the vicious circle among obesity, and insulin.

The diabetes medication rosiglitazone has been associated with a reduction in the likelihood of developing the eye disease called proliferative diabetic retinopathy. A study published in the June issue of Archives of Ophthalmology also found that diabetes patients using the drug were less likely to have reductions in visual acuity …

Loading up on protein and carbohydrates at breakfast may help obese patients with metabolic syndrome stick to a low-calorie, low-carbohydrate diet the rest of the day, researchers found.

Patients with hypertension who monitored their blood pressure from home and received Web-based pharmacist care showed greater improvement in blood pressure control than patients who received usual care, according to a study.

Alogliptin, an investigational once-daily oral drug for type 2 diabetes, showed good efficacy and safety both as monotherapy and together with standard agents, researchers in five phase III trials stated at ADA Scientific Sessions.

Pioglitazone (Actos) may prevent or delay progression to diabetes for patients with pre-diabetes by 81%, researchers found.

Nearly half of patients taking exenatide (Byetta) for type 2 diabetes for more than a year in a small study discontinued it because of loss of efficacy, although many were combining it with insulin off-label. See Publisher’s Comments

A long-acting version of the injectable diabetes drug exenatide (Byetta) showed efficacy advantages and safety comparable to the standard formulation given twice a day, researchers said.

For diabetic patients recently started on long-acting insulin, mealtime pramlintide (Symlin) may boost blood sugar control similar to rapid-acting insulin but with fewer side effects, researchers found.

For obese patients with diabetes, a Teflon-like sleeve placed inside the small intestine just beyond the stomach iimproves glycemic control quickly and markedly.